Dengue fever: the urgent hunt for antivirals and vaccines
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers overcome obstacles to…
By
Infectious Disease
Latest in
Infectious Disease
AIM ImmunoTech provides Phase III efficacy update on Ampligen for long Covid
Treatment with investigational drug Ampligen for a minimum of 12 weeks offered a decline in fatigue in long Covid patients.
Moderna, IAVI to commence Phase I trial of mRNA HIV vaccine trial in Africa
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
Humanetics extends long Covid drug trial to more sites
The trial will analyse BIO 300’s ability to alleviate long-term pulmonary damage in Covid-19 survivors.
Gilead’s lenacapavir for HIV has clinical hold lifted by FDA
All activities in the trials assessing injectable lenacapavir to treat and prevent HIV can resume with the latest development.
Moderna’s Covid-19 vaccine trial in Africa receives support from CRO Emmes
The CRO will carry out data and statistical assessment to determine the relative risks of Covid-19 and severe disease.
Syphilis continues to rise in US despite Covid-19 pandemic restrictions
Recent data from the US CDC found there were 133,945 diagnosed incident cases of syphilis in the US in 2020,…
By
Akston doses first subjects in Phase II Covid-19 booster trial
Being carried out at the UMCG in the Netherlands, the trial will enrol healthy adult subjects aged between 18 and…